Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Nouriel Roubini Talks Markets and Money
07:34

Former Fed Govenor Stephen Miran Talks Fed, Relationship with Trump
11:18

PIMCO's Tiffany Wilding Talks Chip Stocks, Consumer Sentiment
06:51